Risk of Alzheimer's Disease and Alzheimer's Disease‐Related Dementias with liraglutide compared to semaglutide and dulaglutide in veterans with type 2 diabetes: An emulated clinical trial observational study

Abstract

Background: Liraglutide, semaglutide and dulaglutide are non‐exendin based GLP‐1RA that are widely used in type 2 diabetes (T2D) management. GLP‐1RA use may be associated with lower risk of dementia, however, intra‐class effects of GLP‐1RA on AD/ADRD risk need to be further elucidated.

The paper